Department

Department Protocols

The Use Of Amifostine Plus Pilocarpine To Provide Relief Of Oral Side Effects In Head And Neck Cancer Patients Undergoing Radiation Treatment
Status: Active Enrolling’
PI: Mary E. Brosky
Contact: Mary E. Brosky 612 625 6969

Timing Of Rectal Cancer Response TO Chemoradiation
Status: Protocol temporarily on hold while protocol is amended
PI: David Rothenberger
Data Collector: Kate Boulanger RN 612 626 2569

Twin Cities Brachytherapy Study For Ductal Carcinoma In Situ: A Phase II Trial
Status: Active Enrolling
PI: Todd Tuttle, MD
Sub-Investigator: L. Chinsoo Cho, MD
Data Collector: Juliette Gay, RN, 612 625 2956

Allos Protoccol RT-016 A Phase III Randomized, Open-Label Comparative Study Of Standard Whole Brain Radiation Therapy With Supplemental Oxygen, With or Without Concurrent RSR13 (Efaproxiral), in Women With Brain Metastases From Breast Cancer
PI: Kathryn Dusenbery MD 612 626 6146

A Phase I Study of Oxalipatin in Combination With Docetaxel and Radiotherapy in Patients with Unresectable or Recurrent Non-Small Cell Lung Cancer (NSCLC) (OX-04-007)
Status: Open for accrual
PI: L. Chinsoo Cho, MD
Data Collector: Diane Mosel, RN 612-626-2627

Phase II pilot study of TPF (docetaxel, cisplatin, and 5-FU) in chemotherapy followed by concurrent cisplatin and reduced radiation in locally advanced head and neck cancer
Status: Open and Enrolling
PI: Nasfat Shehadeh
Contact: Kate Cole, RN 612-625-5602

A Phase I Trial of Stereotactic Radiosurgery for Patients with Hepatic Metastases
Status: Open and Enrolling
PI: L. Chinsoo Cho, MD
Contact: Diane Mosel, RN 612-626-2627

Phase I and II Study of Stereotactic Body Radiation Therapy (SBRT) for Low and Intermediate Risk Prostate Cancer
PI L. Chinsoo Cho, M.D.
Status: Open and Enrolling
Contact person: Diane Mosel R.N. 612-626-2627